• Health Care

Eisai: Data Safety Monitoring Board Recommends Continuation of Phase III Clinical Studies of Bace Inhibitor Elenbecestat in Early Alzheimer’s Disease

Tokyo June 05, 2019 - (JCN Newswire) - Eisai Co., Ltd. announced today that in the 8th meeting of the…